Aroa Biosurgery Revenue and Competitors

NZ

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Aroa Biosurgery's estimated annual revenue is currently $71M per year.(i)
  • Aroa Biosurgery's estimated revenue per employee is $251,000

Employee Data

  • Aroa Biosurgery has 283 Employees.(i)
  • Aroa Biosurgery grew their employee count by 6% last year.

Aroa Biosurgery's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$74M29530%N/AN/A
Add Company

What Is Aroa Biosurgery?

Aroa Biosurgery is a privately held soft-tissue repair company commercializing regenerative tissue substitutes for medical indications based on their proprietary Endoform® extracellular matrix (ECM) platform. The company was founded in February 2008 based on intellectual property relating to the use of a novel form of ECM isolated from forestomach extracellular matrix for use in tissue regeneration applications. Aroa’s focus is delivering better healing, every day, everywhere for everybody. Aroa’s products make a meaningful impact for patients, surgeons and clinicians. Aroa delivers high quality, simple to use products that significantly improve outcomes. Aroa also believes its products should be widely accessible, affordable and change the standard of care for many patients. Maori for ‘understanding’, Aroa is at the forefront of understanding how biology, structural form and human factors can unlock the body’s intrinsic power to heal.

keywords:N/A

N/A

Total Funding

283

Number of Employees

$71M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aroa Biosurgery News

2022-03-30 - Biosurgery Market to Reach $27.32 Bn, Globally, by 2030 at ...

Aroa Biosurgery Limited; B. Braun Melsungen AG; Baxter International Inc. Becton, Dickinson and Company; Hemostasis LLC...

2022-03-22 - Soft Tissue Repair Market worth $17.2 billion in 2027 ...

(US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition,...

2021-11-25 - Aroa Biosurgery : Half Yearly Report Update Amendment

ASX ANNOUNCEMENT/MEDIA RELEASE 25 November 2021 For personal use only A R O A B I O S U R G E R Y H A L F Y E A R L Y R E P O R T U P D A T E A M E N D M E N T Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, 'AROA' or the 'Company') refers to announcement lodged on the MAP ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$102.7M2836%N/A
#2
$65.4M2838%N/A
#3
$45.1M283N/AN/A
#4
$15M2830%N/A
#5
$84.1M283-14%N/A